Elevation Oncology, Inc. (ELEV) Tops Q1 EPS by 6c

Elevation Oncology, Inc. (NASDAQ: ELEV) reported Q1 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Elevation Oncology, Inc. (ELEV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• SanDisk upgraded at JPMorgan after investor day; shares climb